Progress
Cumulative vaccinations in Algeria [17]
 | Graphs are unavailable due to technical issues. |
Daily vaccinations chart of Algeria
| Graphs are unavailable due to technical issues. |
| Date | 29 January 2021 |
|---|---|
| Location | vaccination clinics |
| Cause | COVID-19 pandemic |
| Participants | 2,500,000 doses administered Sputnik V and Oxford-AstraZeneca (6 June 2021) 2,500,000 Total vaccinated people (to which the first and second dose of vaccine were administered) |
| Footage | https://corona-dz.live/ |
On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. [1] [2] Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines. [3] [4]
Algeria has reported on administering over 2.5 million doses of the vaccine. Data is only reported every few weeks or months apart without secondary dose information. [5] [6]
On 28 January 2021, Algeria received 50,000 doses of Russia's Sputnik V vaccine which landed at Algiers International Airport. [7]
On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of Russia's Sputnik V vaccine. [8]
On 1 February, 50,000 doses of the Oxford–AstraZeneca COVID-19 vaccine arrived. [9]
On 25 February 2021, Algeria received 200,000 more vaccines from China. [10]
364,800 doses of the Oxford-AstraZeneca vaccine were delivered on 3 April through the COVAX pillar. [11] [12]
On 7 April, minister Lotfi Benbahmad announced that an agreement had been reached to produce Sputnik V at Saidal's manufacturing plant in Constantine. [13] [14]
On 26 April, the U.S. provided more than 600,000 doses of the Johnson & Johnson COVID-19 vaccine. [15]
By the end of the month, 4.1 million vaccine doses had been administered. [16]
By the end of the month, 10.2 million vaccine doses had been administered. [16]
By the end of the month, 11.2 million vaccine doses had been administered while 27% of the target population had been fully vaccinated. [16]
By the end of the month, 12.1 million vaccine doses had been administered while 30% of the target population had been fully vaccinated. [16]
By the end of the month, 12.5 million vaccine doses had been administered while 31% of the target population had been fully vaccinated. [16]
By the end of the month, 13 million vaccine doses had been administered while 32% of the target population had been fully vaccinated. [16]
By the end of the month, 15 million vaccine doses had been administered while 6.5 million persons had been fully vaccinated. [16]
Cumulative vaccinations in Algeria [17]
| Graphs are unavailable due to technical issues. |
Daily vaccinations chart of Algeria
| Graphs are unavailable due to technical issues. |
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.
COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
Burkina Faso started vaccinating against COVID-19 on 2 June 2021.
Cape Verde has begun vaccinations against COVID-19.
COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.
COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.
Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.
COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.
COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
